Cite
Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo.
MLA
Fu, Dong-Jun, et al. “Discovery of Novel Tertiary Amide Derivatives as NEDDylation Pathway Activators to Inhibit the Tumor Progression in Vitro and in Vivo.” European Journal of Medicinal Chemistry, vol. 192, Apr. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2020.112153.
APA
Fu, D.-J., Song, J., Zhu, T., Pang, X.-J., Wang, S.-H., Zhang, Y.-B., Wu, B.-W., Wang, J.-W., Zi, X., Zhang, S.-Y., & Liu, H.-M. (2020). Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo. European Journal of Medicinal Chemistry, 192, N.PAG. https://doi.org/10.1016/j.ejmech.2020.112153
Chicago
Fu, Dong-Jun, Jian Song, Ting Zhu, Xiao-Jing Pang, Sheng-Hui Wang, Yan-Bing Zhang, Bo-Wen Wu, et al. 2020. “Discovery of Novel Tertiary Amide Derivatives as NEDDylation Pathway Activators to Inhibit the Tumor Progression in Vitro and in Vivo.” European Journal of Medicinal Chemistry 192 (April): N.PAG. doi:10.1016/j.ejmech.2020.112153.